跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PHARMACOR EVEROLIMUS everolimus 1 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
PHARMACOR EVEROLIMUS everolimus 1 mg tablet blister pack
Approved
STANDARD
PHARMACOR EVEROLIMUS everolimus 1 mg tablet blister pack
Pharmacor Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
f216671ad388427d
Company
Pharmacor Pty Ltd
Type
Standard
Approval Details
Approval Id
f216671ad388427d
Product Name
PHARMACOR EVEROLIMUS everolimus 1 mg tablet blister pack
Artg Id
335149
Artg Name
PHARMACOR EVEROLIMUS everolimus 1 mg tablet blister pack
Sponsor
Pharmacor Pty Ltd
Company Detail Path
/organization/pharmacor-sa-pty-ltd
Artg Date
2021-04-21
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/04eb41e582f5828ac1de7a2d86eb030e.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/9ffa178063f3bdb919808a5fb09e531f.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
f216671ad388427d
Type
Standard
Back to TGA Approvals